Omega Healthcare Investors Inc OHI
Institutional shares held
153 Million
1.78M
calls
616K
puts
Total value of holdings
$5.1B
$59.3M
calls
$20.5M
puts
Market Cap
$7.78B
234,111,008
Shares Out.
Institutional ownership
65.57%
# of Institutions
559
We take great care to ensure that the data presented and summarized in this overview for OMEGA HEALTHCARE INVESTORS INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding OHI
View all-
Vanguard Group Inc Valley Forge, PA35.4MShares$1.18 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY29MShares$963 Million0.02% of portfolio
-
State Street Corp Boston, MA12.5MShares$416 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA5.92MShares$197 Million0.02% of portfolio
-
Centersquare Investment Management LLC Plymouth Meeting, PA3.57MShares$119 Million1.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA3.55MShares$118 Million0.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.46MShares$115 Million0.03% of portfolio
-
Balyasny Asset Management LLC Chicago, IL2.72MShares$90.4 Million0.16% of portfolio
-
Amundi Paris, I02.39MShares$79.4 Million0.03% of portfolio
-
Bank Of America Corp Charlotte, NC2.32MShares$77.2 Million0.01% of portfolio
Latest Institutional Activity in OHI
Top Purchases
Top Sells
About OHI
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
Insider Transactions at OHI
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 21
2024
|
Robert O Stephenson CHIEF FINANCIAL OFFICER |
SELL
Bona fide gift
|
Direct |
1,850
-0.78%
|
-
|
|
Jun 07
2024
|
Burke W Whitman |
BUY
Grant, award, or other acquisition
|
Direct |
4,605
+10.38%
|
$147,360
$32.57 P/Share
|
|
Jun 07
2024
|
Lisa Egbuonu Davis |
BUY
Grant, award, or other acquisition
|
Direct |
4,605
+20.27%
|
$147,360
$32.57 P/Share
|
|
Jun 07
2024
|
Kevin J Jacobs |
BUY
Grant, award, or other acquisition
|
Direct |
7,522
+18.25%
|
$240,704
$32.57 P/Share
|
|
Mar 31
2024
|
Neal Ballew CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
13
-0.43%
|
$403
$31.67 P/Share
|
|
Mar 31
2024
|
Neal Ballew CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
240
+7.31%
|
$6,240
$26.07 P/Share
|
|
Jan 02
2024
|
Neal Ballew CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
13
-0.46%
|
$390
$30.66 P/Share
|
|
Jan 02
2024
|
Neal Ballew CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
239
+7.82%
|
$6,214
$26.07 P/Share
|
|
Dec 31
2023
|
Gail D Makode CHIEF LEGAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
142
+11.06%
|
-
|
|
Dec 31
2023
|
Daniel J Booth CHIEF OPERATING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
10,712
-4.93%
|
$321,360
$30.66 P/Share
|
|
Dec 31
2023
|
Daniel J Booth CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
22,051
+9.21%
|
$661,530
$30.66 P/Share
|
|
Oct 02
2023
|
Neal Ballew CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
13
-0.5%
|
$416
$32.62 P/Share
|
|
Oct 02
2023
|
Neal Ballew CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
240
+8.48%
|
$6,240
$26.09 P/Share
|
|
Sep 26
2023
|
Robert O Stephenson CHIEF FINANCIAL OFFICER |
SELL
Bona fide gift
|
Direct |
1,500
-0.63%
|
-
|
|
Jul 03
2023
|
Neal Ballew CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
253
+9.72%
|
$6,831
$27.41 P/Share
|
|
Jun 05
2023
|
Burke W Whitman |
BUY
Grant, award, or other acquisition
|
Direct |
4,995
+12.44%
|
$149,850
$30.03 P/Share
|
|
Jun 05
2023
|
Kevin J Jacobs |
BUY
Grant, award, or other acquisition
|
Direct |
8,158
+23.76%
|
$244,740
$30.03 P/Share
|
|
Jun 05
2023
|
Lisa Egbuonu Davis |
BUY
Grant, award, or other acquisition
|
Direct |
4,995
+26.99%
|
$149,850
$30.03 P/Share
|
|
May 17
2023
|
Daniel J Booth CHIEF OPERATING OFFICER |
SELL
Bona fide gift
|
Direct |
250
-0.13%
|
$7,250
$29.49 P/Share
|
|
Apr 03
2023
|
Neal Ballew CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
253
+10.76%
|
$6,578
$26.79 P/Share
|
Last 12 Months Summary
Buy / Acquisition
39.9K
Shares
From
6
Insiders
| Grant, award, or other acquisition | 17.8K shares |
|---|---|
| Exercise of conversion of derivative security | 22.1K shares |
Sell / Disposition
14.1K
Shares
From
3
Insiders
| Payment of exercise price or tax liability | 10.8K shares |
|---|---|
| Bona fide gift | 3.35K shares |